Daniel M. Aebersold
Papers
4
Total Citations
17
H-Index
2
About
Daniel M. Aebersold is a radiation oncology researcher whose work centers on the advancement of stereotactic body radiation therapy (SBRT) and robotic radiosurgery technologies. His research focuses on refining treatment precision, optimizing dose delivery, and expanding the clinical applicability of CyberKnife-based systems in challenging oncological scenarios. Among his most notable contributions is his investigation into the feasibility of postoperative spine SBRT in patients with carbon fiber reinforced polyetheretherketone and titanium hybrid implants — a technically demanding area that has garnered significant attention, accumulating 10 citations since its 2022 publication. This work addresses a critical gap in knowledge regarding radiation planning near complex spinal hardware, directly informing clinical practice for post-surgical cancer patients. His comparative analysis of five- versus seven-fraction SBRT regimens for intermediate- and high-risk prostate cancer further demonstrates his commitment to evidence-based protocol optimization, helping clinicians balance efficacy with toxicity. Additionally, his evaluation of the InCise 2 multi-leaf collimator system contributes valuable technical insight into treatment planning quality for brain and liver tumors. Collectively, Aebersold's work enhances the safety, precision, and versatility of modern stereotactic radiotherapy, making him a meaningful contributor to the evolving landscape of radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4